Feeds › Clinical trial updates
Clinical trial updates
Drug and device trials that companies register on ClinicalTrials.gov: newly completed phase 3 studies, changes of status and the dates a study is due to finish.
About this data
- What it is
- ClinicalTrials.gov is the US registry of clinical studies. Drug and device makers register their trials there and update the record as each study moves on. We list the studies that companies sponsor, and match the sponsor to a public company when the name lines up. The page opens on Phase 3 studies marked completed, the late-stage trials that come before a request for approval. Change View to see the changes of status we have noticed, or every recent update.
- Who files it
- The sponsor of the study, in its record on ClinicalTrials.gov. The registry is run by the US National Library of Medicine and does not check what sponsors report.
- How current
- We check the registry every day. Sponsors update records on their own schedule, from the same week to months later, so a change can appear in the registry well after it happened.
- Terms
- ClinicalTrials.govClinicalTrials.gov is the US government's registry of clinical studies, run by the National Library of Medicine. Sponsors register a study before it starts and update the record as it goes. The registry does not check what a sponsor reports.Phase 3The late stage of testing, usually with hundreds or thousands of people, to confirm that a treatment works and to find side effects. A study marked Phase 2/3 covers both stages.statusThe registry's own word for where a study stands: not yet recruiting, recruiting, active but not recruiting, completed, terminated (stopped early), withdrawn (never started), suspended, or unknown (the sponsor has not confirmed the record for a long time).completedThe sponsor has marked the study as finished. It says nothing about whether the treatment worked: results, if any, are reported separately and often later.status changesOur history of status changes starts the day we first stored each study, so a change made before that is not shown. The date is when we noticed the change, which can be later than when the sponsor made it.primary completionThe date the last participant is examined for the main question the study asks. The study can run on after it, for follow-up. Sponsors enter the date and revise it, and an estimated date can pass without an update.company matchWe match the sponsor's name to a public company automatically, and by hand for the large drugmakers. A subsidiary or a differently spelled name can be missed, so a study with no ticker does not mean the sponsor is private.
- Worth knowing
- A completed study is not a result: the registry says the study ended, not whether the treatment worked. Status changes start on the day we first stored each study, so earlier changes are not shown. Dates are the sponsor's own, and an estimated date can pass without an update. We match sponsors to companies automatically, with a hand-checked list for the large drugmakers, so a study with no ticker may still belong to a public company. This is information about studies, not a forecast of what they will show or of a stock's price.
- Not to be confused with
- FDA approvals and clearances: what the FDA decided, not what a sponsor reports about a study.
All of this comes from ClinicalTrials.gov, the US registry of clinical studies. We are not affiliated with it.
Source and freshness · Information, not investment advice (disclaimer).
Studies updated per day, last 30 days
All industry-sponsored studies Sponsor matched to a public company
By the day the sponsor last updated the study's record. A study updated twice counts once, on its latest day.
Latest clinical trial updates
Showing: ticker RCEL · All recent updates
Studies by the date their record was last updated.
| Updated | Study | SponsorWe match the sponsor's name to a public company automatically, and by hand for the large drugmakers. A subsidiary or a differently spelled name can be missed, so a study with no ticker does not mean the sponsor is private. | PhaseThe late stage of testing, usually with hundreds or thousands of people, to confirm that a treatment works and to find side effects. A study marked Phase 2/3 covers both stages. | StatusThe registry's own word for where a study stands: not yet recruiting, recruiting, active but not recruiting, completed, terminated (stopped early), withdrawn (never started), suspended, or unknown (the sponsor has not confirmed the record for a long time). | Enrolled | Primary completionThe date the last participant is examined for the main question the study asks. The study can run on after it, for follow-up. Sponsors enter the date and revise it, and an estimated date can pass without an update. | Source |
|---|---|---|---|---|---|---|---|
| Sep 23, 2026 | Multicenter Single-arm Trial to Investigate Clinical Outcomes When Cohealyx™ is Used for Full Thick… NCT06787690 · Burn, Trauma Wound Cohealyx | RCEL Avita Medical | Not applicable | Completed | 41 | Feb 10, 2026 | Registry ↗ |
| Sep 23, 2026 | Randomized Controlled Trial to Investigate Clinical Outcomes and Associated Costs When PermeaDerm i… NCT06750809 · Surgical Wound, Trauma Wound PermeaDerm Biosynthetic Wound Matrix, Frozen Human Cadaveri… | RCEL Avita Medical | Not applicable | Completed | 40 | Mar 18, 2026 | Registry ↗ |
| Feb 6, 2025 | Repigmentation of Stable Vitiligo Lesions Using Spray-On Skin™ Cells NCT05971381 · Vitiligo RECELL® Autologous Cell Harvesting Device | RCEL Avita Medical | Not applicable | Completed | 109 | Jul 30, 2024 | Registry ↗ |
| Jan 7, 2025 | ReCell® Combined With Meshed Skin Graft in the Treatment of Acute Burn Injuries NCT02380612 · Burns ReCell Treatment, Skin Graft | RCEL Avita Medical | Not applicable | Completed | 30 | Jan 21, 2016 | Registry ↗ |
| Jul 30, 2024 | RECELL® System Combined With Meshed Autograft for Reduction of Donor Skin Harvesting in Soft Tissue… NCT04091672 · Full-thickness Skin Defects, Degloving Injuries Control Intervention (Conventional Autograft), Investigatio… | RCEL Avita Medical | Not applicable | Completed | 65 | Mar 7, 2022 | Registry ↗ |
| Jul 30, 2024 | RES® Prepared With RECELL® Compared to Standard of Care Dressings of Partial-thickness Burns in Age… NCT03626701 · Burns RES (Regenerative Epidermal Suspension) prepared using the… | RCEL Avita Medical | Not applicable | Terminated | 19 | Jun 23, 2021 | Registry ↗ |
| Jul 30, 2024 | Continued Access to the Recell® Device for Treatment of Acute Burn Injuries NCT03333941 · Burns ReCell® Autologous Cell Harvesting Device | RCEL Avita Medical | — | Completed | 76 | Dec 19, 2018 | Registry ↗ |
| Jul 30, 2024 | CONTINUED ACCESS PROTOCOL: Demonstration of the Safety and Effectiveness of ReCell® Combined With M… NCT02994654 · Burns ReCell | RCEL Avita Medical | Not applicable | Completed | 12 | Dec 2017 | Registry ↗ |
| Jul 18, 2024 | RES Prepared With RECELL® Compared to Conventional Care for Healing of Donor Sites in Ages 1-16 Yea… NCT03624192 · Skin; Deformity RECELL® Autologous Cell Harvesting Device, Telfa™ Clear and… | RCEL Avita Medical | Not applicable | Terminated | 3 | Jan 13, 2020 | Registry ↗ |
| May 24, 2024 | Clinical Study to Investigate the Safety and Effectiveness of RECELL for Repigmentation of Stable V… NCT04547998 · Vitiligo Control Intervention (UVB), Investigational Interventions (… | RCEL Avita Medical | Not applicable | Completed | 25 | Jun 28, 2022 | Registry ↗ |
| Mar 14, 2023 | Feasibility Study to Evaluate RECELL and Melanocyte Keratinocyte Transplantation Procedure for Repi… NCT04271501 · Vitiligo Melanocyte-Keratinocyte Transplantation and Ultraviolet Lam… | RCEL Avita Medical | Not applicable | Terminated | 5 | Aug 24, 2021 | Registry ↗ |
| Aug 3, 2020 | Prospective Evaluation of the ReCell® Autologous Cell Harvesting Device For Specific Compassionate… NCT02992249 · Burns | RCEL Avita Medical | — | Completed | 100 | May 2019 | Registry ↗ |
| Jun 21, 2019 | A Feasibility Study of the ReGenerCell™ Autologous Cell Harvesting Device for Diabetic Foot Ulcers NCT02799121 · Diabetic Foot Ulcer ReGenerCell™ Autologous Cell Harvesting Device | RCEL Avita Medical | Phase 4 | Completed | 16 | Mar 29, 2019 | Registry ↗ |
| May 13, 2019 | A Multicenter Comparative Study of the ReCell Device and Autologous Split-thickness Meshed Skin Gra… NCT01138917 · Burns ReCell and Split-thickness skin graft | RCEL Avita Medical | Not applicable | Completed | 101 | Aug 29, 2014 | Registry ↗ |
| Jun 8, 2016 | A Pilot Trial of the Use of ReCell® Autologous Cell Harvesting Device for Venous Leg Ulcers NCT01743053 · Venous Leg Ulcers Standard Care plus ReCell, Standard Care | RCEL Avita Medical | Phase 4 | Completed | 52 | Oct 2015 | Registry ↗ |
15 items, most recent first (up to 50). Each row links to the study's page on ClinicalTrials.gov. Updated Nov 15, 2026, 7:08 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · FDA approvals and clearances